RxDoctor Payments DataLook up a doctor →

William E Torres, MD

General Practice · San Juan, PRNPI 1144460684

Payments from drug & device makers

$86,329in general payments, 2019–2025

Across 1,501 payments — averaging $57.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$62K
  • AstraZeneca$4K
  • Novo Nordisk$3K
  • GSK$2K
  • Lilly USA, LLC$2K
  • Biohaven Pharmaceuticals, Inc.$2K
  • plus $12K from 54 others

What the payments were for

  • Consulting fees$1,2001%
  • Speaking & faculty fees$55,28164%
  • Travel & lodging$3,0834%
  • Food & beverage$26,72631%
  • Education$390%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)325$61,987
AstraZeneca199$3,996
Novo Nordisk153$2,810
GSK80$1,883
Lilly USA, LLC121$1,840
Biohaven Pharmaceuticals, Inc.9$1,603
Pfizer97$1,411
Bayer47$1,029
Sanofi-aventis U.S. LLC40$768
Mylan Specialty L.p.24$610
Renalytix AI, Inc.29$596
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC28$576
Boehringer Ingelheim29$520
Nestle Healthcare Nutrition Inc.29$461
Esperion Therapeutics, Inc.20$461
Novartis27$413
Gilead14$385
Otsuka America Pharmaceutical, Inc.13$381
Amarin Pharma, Inc.41$350
Intuity Medical Inc5$321
Vanda Pharmaceuticals Inc.12$289
E.r. Squibb & Sons, L.L.C.11$287
Johnson & Johnson8$219
Amgen9$199
Aimmune Therapeutics, Inc.14$197
Eisai Inc.5$188
Exact Sciences8$186
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$166
Xeris Pharmaceuticals, Inc.9$164
Stryker1$163
Merck12$158
Abbott8$152
Painteq LLC1$140
Cipher Pharmaceuticals US LLC1$138
Takeda Pharmaceuticals U.S.A., Inc.6$122
Alkermes, Inc.5$122
Astellas Pharma US Inc5$104
Scpharmaceuticals Inc.4$90
Intra-sana Laboratories3$70
Amneal Pharmaceuticals LLC3$69
Axsome Therapeutics, Inc.3$66
Kowa Pharmaceuticals America, Inc.4$57
Corcept Therapeutics3$49
Bausch Health US, LLC2$46
Shield Therapeutics Inc2$43
Ardelyx, Inc.2$41
Scynexis, Inc.2$40
Smith+Nephew2$29
Lexicon Pharmaceuticals, Inc.1$28
Forte Bio-pharma LLC2$27
Radius Health, Inc.1$26
Hologic Sales And Service, LLC1$24
Advanced Respiratory, Inc1$22
Idorsia Pharmaceuticals US Inc1$21
Lifescan, Inc.1$21
Arbor Pharmaceuticals, Inc.1$20
Lundbeck LLC1$20
Corium, LLC1$17
Biohaven Pharmaceutical Holding Company Ltd.1$17
Eyevance Pharmaceuticals LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$86,329 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$19,786
Medicare patients
85
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide232$294,088
JardianceEmpagliflozin197$228,561
EliquisApixaban233$197,623
FarxigaDapagliflozin Propanediol152$191,250
Enbrel SureclickEtanercept16$137,514
Trelegy ElliptaFluticasone/Umeclidin/Vilanter154$132,611
VraylarCariprazine Hcl70$104,366
TrulicityDulaglutide71$89,388
GlyxambiEmpagliflozin/Linagliptin75$86,770
Breztri AerosphereBudesonide/Glycopyr/Formoterol78$82,258
MounjaroTirzepatide60$80,601
Soliqua 100-33Insulin Glargine/Lixisenatide70$72,591
EntrestoSacubitril/Valsartan53$70,365
Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf)59$69,530
LinzessLinaclotide60$66,370

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi, Spiriva Respimat, Combivent Respimat, Tradjenta$520$405,177383 claims
Novo NordiskOzempic, Rybelsus$2,810$330,186266 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$3,996$295,645292 claims
AbbVieVraylar, Linzess, Ubrelvy$61,987$209,187157 claims
PfizerEliquis$1,411$197,623233 claims
Lilly USA, LLCTrulicity, Mounjaro$1,840$169,988131 claims
GSKTrelegy Ellipta, Anoro Ellipta$1,883$162,967200 claims
GileadBiktarvy, Descovy$385$104,20934 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$768$72,59170 claims
NovartisEntresto$413$70,36553 claims
Aimmune Therapeutics, Inc.Zenpep$197$59,73022 claims
BayerKerendia$1,029$54,62541 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,586 general practice providers in Puerto Rico.

Other general practice in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →